Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
1.0 CME/NCPD/CPE | VA/DoD Meeting Series
This activity will discuss emerging efficacy and safety data on novel therapies for nmCRPC and mCRPC, strategies to manage adverse events, and the role of imaging studies and PSA testing in evaluating treatment response. Schedule a meeting today!
